Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Testing effectiveness (Phase 2)Study completedNCT03025542
What this trial is testing

Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 49
Post-approval studies (Phase 4)Study completedNCT03587194
What this trial is testing

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT01045577
What this trial is testing

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AB Science 25
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT01166646
What this trial is testing

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 43
Not applicableUnknownNCT01339741
What this trial is testing

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Who this might be right for
Psoriasis VulgarisVitamin D Deficiency
Chulalongkorn University 30
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Testing effectiveness (Phase 2)Study completedNCT06972888
What this trial is testing

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Accro Bioscience (Suzhou) Limited 145
Large-scale testing (Phase 3)Study completedNCT02489227
What this trial is testing

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 545
Post-approval studies (Phase 4)Study completedNCT03573323
What this trial is testing

Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 1,027
Not applicableNot Yet RecruitingNCT07382388
What this trial is testing

A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Peking University Third Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01072383
What this trial is testing

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Biotest 49
Testing effectiveness (Phase 2)Study completedNCT04603027
What this trial is testing

Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Evelo Biosciences, Inc. 249
Large-scale testing (Phase 3)Looking for participantsNCT07672561
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Zhejiang Wenda Pharma Technology LTD. 375
Testing effectiveness (Phase 2)Study completedNCT00292396
What this trial is testing

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 180
Large-scale testing (Phase 3)Ended earlyNCT00358670
What this trial is testing

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 441
Large-scale testing (Phase 3)Study completedNCT04761627
What this trial is testing

Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 494
Large-scale testing (Phase 3)Study completedNCT05763082
What this trial is testing

Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Padagis LLC 416
Post-approval studies (Phase 4)Study completedNCT04645355
What this trial is testing

Guselkumab Immunogenetics

Who this might be right for
Psoriasis GuttatePlaque Psoriasis
University of California, San Francisco 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation